The L.A. Hotel Downtown
Los Angeles, California
GOOD SAMARITAN HOSPITAL
Los Angeles, CA
AMERICAN COLLEGE OF CARDIOLOGY
FOURTH ANNUAL SYMPOSIUM
Contemporary Management of
Cardiovascular Disease in Women
February 9, 2019
IMPORTANT CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed.
Surveys are accessible after logging in with the email address you submitted during registration.
Surveys will be accessible online the day of the symposium and for 3 weeks following. You must complete the
process by March 4, 2019 in order to receive your certificate. Certificates will be available online until October 1, 2019
and are printable directly from the website.
CME SURVEYS, PRESENTATION SLIDES AND SYLLABUS
Login required for access to conference materials.
This Live activity, 4th Annual Contemporary Management of Cardiovascular Disease in Women, with a beginning date of February 9, 2019 has been reviewed and is acceptable for up to 7.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA: AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award.
AANPCP: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AAFP Prescribed credit.
ANCC: According to the ANCC, the continuing education hours approved by the AAFP meet the ANCC-accredited CNE criteria.
AAPA: The American Academy of Physician Assistants accepts AAFP Prescribed credit for AAPA Category 1 CME credit.
This educational symposium will define risk factors for cardiovascular disease in women and how they differ from men, the impact of cardiovascular disease in women worldwide, and gender-specific treatments. Discussions will include pathophysiology of pregnancy related complications, the risks and benefits of hormone therapy, the benefits of biventricular therapy in women and heart failure management, and advances in management of dyslipidemia, atrial fibrillation and coronary microvascular dysfunction. State of the art therapies for structural heart disease, with an emphasis on outcomes in women, will be discussed.
The objective of this symposium is to educate healthcare providers on gender-appropriate approaches in prevention, diagnosis and treatment of women with a broad range of cardiovascular diseases.
At the conclusion of this activity, the participants should be able to:
1. Be aware of the current epidemiology of cardiovascular disease in women
2. Review the current recommendations regarding hormone therapy for the treatment of menopause
3. Discuss the most up to date therapies for pulmonary arterial hypertension
4. Understand the current studies and management of women with ischemia without obstructive CAD
5. Review dyslipidemia therapies and specific outcomes in women
6. Be aware of the gender specific outcomes between TAVR and SAVR
7. Explore the expanding indications for MitraClip
8. Understand the role of PFO closure in cyptogenic stroke
9. Recognize the most current dietary interventions to prevent cardiovascular disease
10. Discuss the diagnosis and management of valvular heart disease in pregnancy
11. Examine the changing indications for DOACs and reversal agents
12. Recognize age-specific considerations in the placement of cardiac implantable electronic devices in women
13. Explore the spectrum of the dysautonomic syndromes, their diagnosis and management
14. Understand the basic fundamentals of ECG reading and be able to recognize the most common clinical ECG diagnoses
15. Be able to recognize a wide range of cardiovascular disorders affecting women by examining complete case studies, including presentations, work-ups, and therapies
Heart disease is the leading cause of death in women in the US and accounts for more deaths each year than all other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of a heart attack. Compared to men, women are less likely to receive standard of care treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the risk of heart disease in women and empower them to be advocates for women's cardiovascular health.
This educational symposium with define risk factors for cardiovascular disease in women and how they differ from men, the impact of cardiovascular disease in women worldwide, and gender-specific treatments.
This program has been designed to provide primary care physicians, internists,
cardiologists, nurse practitioners, physician assistants, nurses, pharmacists
and other healthcare providers with the necessary information to increase
knowledge and awareness of cardiovascular disease in women with the goal
of improving patient care.
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individualís control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speakerís outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.